{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T04:02:18Z","timestamp":1750046538710,"version":"3.41.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Adv Skin Wound Care"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>To evaluate the use of a novel skin barrier protectant in a patient treated with radiotherapy for vulvar cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>This case report was conducted in a radiotherapy department with two women undergoing radiotherapy for vulvar carcinoma. A novel skin barrier protectant was evaluated in one patient; the other underwent the institutional standard skin care protocol. Skin reactions and pain were evaluated using the Radiotherapy Oncology Group Criteria.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MAIN RESULTS<\/jats:title>\n            <jats:p>The patient who was treated with the skin protectant showed accelerated healing toward the end of radiotherapy, and this was accompanied with a decrease in pain (maximum pain score 6\/10). In comparison, the patient treated with the standard skin care protocol had an extended healing process, experienced a higher pain level (maximum pain score 9\/10), and required more nursing care.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS<\/jats:title>\n            <jats:p>This case report is the first to suggest that this novel skin barrier protectant could effectively manage acute radiodermatitis in patients with cancer. This case report hopes to lay the foundation for future randomized controlled trials with a larger and broader patient population.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/01.asw.0000722768.95461.82","type":"journal-article","created":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T20:01:15Z","timestamp":1607976075000},"page":"49-55","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Evaluating the Effectiveness of a Novel Skin Barrier Protectant in a Patient with Acute Radiodermatitis of the Vulva: A Case Report"],"prefix":"10.1097","volume":"34","author":[{"given":"Leen","family":"Van Bever","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Claes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolien","family":"Robijns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine","family":"Censabella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Pannekoeke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn","family":"Van de Werf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Bulens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"3","key":"bib1-20250615","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s40257-016-0186-4","article-title":"Radiodermatitis: a review of our current understanding","volume":"17","year":"2016","journal-title":"Am J Clin Dermatol"},{"issue":"12","key":"bib2-20250615","first-page":"885","article-title":"Radiation dermatitis: recognition, prevention, and management","volume":"31","year":"2017","journal-title":"Oncology (Williston Park)"},{"issue":"9","key":"bib3-20250615","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/ijd.13371","article-title":"Radiation dermatitis: an overview","volume":"56","year":"2017","journal-title":"Int J Dermatol"},{"issue":"1","key":"bib5-20250615","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jaad.2005.08.054","article-title":"R0adiation dermatitis: clinical presentation, pathophysiology, and treatment 2006","volume":"54","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"bib6-20250615","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1600-0625.2008.00786.x","article-title":"The skin: an indispensable barrier","volume":"17","year":"2008","journal-title":"Experimental Dermatol"},{"issue":"4","key":"bib7-20250615","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00520-018-4487-4","article-title":"Biophysical skin measurements to evaluate the effectiveness of photobiomodulation therapy in the prevention of acute radiation dermatitis in breast cancer patients","volume":"27","year":"2019","journal-title":"Support Care Cancer"},{"issue":"3","key":"bib8-20250615","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1365-2354.1999.00153.x","article-title":"Skin reactions during radiotherapy for breast cancer: the use and impact of topical agents and dressings","volume":"8","year":"1999","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"3","key":"bib9-20250615","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0167-8140(01)00491-1","article-title":"Studies on radiosensitivity from an epidemiological point of view\u2014overview of methods and results","volume":"62","year":"2002","journal-title":"Radiother Oncol"},{"issue":"2","key":"bib10-20250615","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0167-8140(03)00166-X","article-title":"Personal characteristics, therapy modalities and individual DNA repair capacity as predictive factors of acute skin toxicity in an unselected cohort of breast cancer patients receiving radiotherapy","volume":"69","year":"2003","journal-title":"Radiother Oncol"},{"issue":"1055","key":"bib11-20250615","doi-asserted-by":"crossref","first-page":"20150414","DOI":"10.1259\/bjr.20150414","article-title":"Correlation between anthropometric parameters and acute skin toxicity in breast cancer radiotherapy patients: a pilot assessment study","volume":"88","year":"2015","journal-title":"Br J Radiol"},{"key":"bib12-20250615","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1186\/1471-2407-14-711","article-title":"Factors modifying the risk for developing acute skin toxicity after whole-breast intensity modulated radiotherapy","volume":"14","year":"2014","journal-title":"BMC Cancer"},{"issue":"3","key":"bib13-20250615","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1524-475x.2001.00187.x","article-title":"Dermatitis during radiation for vulvar carcinoma: prevention and treatment with granulocyte-macrophage colony-stimulating factor impregnated gauze","volume":"9","year":"2001","journal-title":"Wound Repair Regen"},{"issue":"3","key":"bib14-20250615","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1046\/j.1365-2133.2001.04115.x","article-title":"Topical granulocyte-macrophage colony-stimulating factor for radiation dermatitis of the vulva","volume":"144","year":"2001","journal-title":"Br J Dermatol"},{"issue":"3C","key":"bib15-20250615","first-page":"3105","article-title":"Radiotherapy alone and chemoirradiation in recurrent squamous cell carcinoma of the vulva","volume":"23","year":"2003","journal-title":"Anticancer Res"},{"issue":"1","key":"bib16-20250615","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3857\/roj.2012.30.1.20","article-title":"Treatment outcome in patients with vulvar cancer: comparison of concurrent radiotherapy to postoperative radiotherapy","volume":"30","year":"2012","journal-title":"Radiat Oncol J"},{"issue":"3","key":"bib17-20250615","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3857\/roj.2015.33.3.198","article-title":"Treatment outcomes of curative radiotherapy in patients with vulvar cancer: results of the retrospective KROG 1203 study","volume":"33","year":"2015","journal-title":"Radiat Oncol J"},{"key":"bib18-20250615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2016.07.007","article-title":"Risk factors and treatment for recurrent vulvar squamous cell carcinoma","volume":"106","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"bib19-20250615","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/sajc.sajc_66_17","article-title":"Conventional radiotherapy and intensity-modulated radiotherapy in carcinoma vulva: an experience from a tertiary medical center of India","volume":"8","year":"2019","journal-title":"South Asian J Cancer"},{"issue":"5","key":"bib20-20250615","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/00129334-200209000-00007","article-title":"Wound care after radiation therapy","volume":"15","year":"2002","journal-title":"Adv Skin Wound Care"},{"issue":"1","key":"bib21-20250615","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.EWX.0000529960.52517.4c","article-title":"Acute and chronic radiodermatitis: clinical signs, pathophysiology, risk factors and management options","volume":"15","year":"2018","journal-title":"J Egypt Womens Dermatol Soc"},{"issue":"10","key":"bib22-20250615","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1007\/s00520-013-1896-2","article-title":"Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group","volume":"21","year":"2013","journal-title":"Support Care Cancer"},{"issue":"3","key":"bib23-20250615","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00520-016-3521-7","article-title":"Topical interventions to prevent acute radiation dermatitis in head and neck cancer patients: a systematic review","volume":"25","year":"2017","journal-title":"Support Care Cancer"},{"issue":"1","key":"bib24-20250615","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0360-3016(03)01431-7","article-title":"Randomized, paired comparison of No-Sting Barrier Film versus sorbolene cream (10% glycerine) skin care during postmastectomy irradiation","volume":"58","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"bib25-20250615","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jfma.2013.04.003","article-title":"3M Cavilon No-Sting Barrier Film or topical corticosteroid (mometasone furoate) for protection against radiation dermatitis: a clinical trial","volume":"114","year":"2015","journal-title":"J Formos Med Assoc"},{"issue":"12","key":"bib26-20250615","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1089\/wound.2015.0628","article-title":"Reducing friction on skin at risk: the use of 3M Cavilon No Sting Barrier Film","volume":"4","year":"2015","journal-title":"Adv Wound Care (New Rochelle)"},{"issue":"4","key":"bib27-20250615","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jaci.2011.12.989","article-title":"Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency","volume":"129","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"bib28-20250615","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/wrr.12455","article-title":"In vivo methods to evaluate a new skin protectant for loss of skin integrity","volume":"24","year":"2016","journal-title":"Wound Repair Regen"},{"issue":"2","key":"bib29-20250615","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/WON.0000000000000307","article-title":"Clinical evaluation of a skin protectant for the management of incontinence-associated dermatitis: an open-label, nonrandomized, prospective study","volume":"44","year":"2017","journal-title":"J Wound Ostomy Continence Nurs"},{"key":"bib30-20250615","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jclinepi.2017.04.026","article-title":"CARE guidelines for case reports: explanation and elaboration document","volume":"89","year":"2017","journal-title":"J Clin Epidemiol"}],"container-title":["Advances in Skin &amp; Wound Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.ASW.0000722768.95461.82","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T21:07:16Z","timestamp":1750021636000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/01.ASW.0000722768.95461.82"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/01.asw.0000722768.95461.82","relation":{},"ISSN":["1538-8654","1527-7941"],"issn-type":[{"type":"electronic","value":"1538-8654"},{"type":"print","value":"1527-7941"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}